It’s just another day in the 2020 biotech IPO boom. Three went public this morning and a fourth gained 75 percent on its Nasdaq trading debut.
Leading the pack is the biological analytics-focused company Berkeley Lights, which priced at $22 per share and raised $178.2 million. Next up is ALX Oncology, which at $19 per share raised $161.5 million. Then comes T-cell biotech Pandion, revising previous numbers to $18 per share and offering an upsized 2 million more shares, raising $135 million.